VIRULENT PROPERTIES OF GENUS CANDIDA IN PATIENTS WITH PERSISTENT BRONCHIAL ASTHMA AND LONG-TERM TREATMENT WITH INHALED STEROIDS
https://doi.org/10.18093/0869-0189-2014-0-3-73-77
Abstract
Methods. In this study, virulent properties of the genus Candida spp. were investigated in oropharyngeal smears of 30 patients with persistent asthma treated with moderate-to-high dose inhaled corticosteroids (ICS) for at least 1 year. A control group included 15 steroid-naive asthmatic patients. Fungi were identified by conventional methods (morphology, presence of germination tubes, chlamydospores, fermentation of carbohydrates). Sensitivity to antibiotics was determined by disk method on the Saburo agar medium. Adhesion was assessed in a model with nitrocellulose film and immobilized hemoglobin. Proteinase activity was measured by the ELISA method in supernatant at two pH values: acidic (pH = 4.5) or weakly alkaline
(pH = 7.8). CD cell leukocyte receptor proteolysis was evaluated by the cytofluorometrics method.
Results. An incidence of fungal colonization of the pharynx in ICS-treated patients with bronchial asthma was 76.7 %. Most strains were highly virulent as they had significantly higher adhesive and enzymatic activity and multi-drug resistance to antifungals compared to control group.
Conclusion. The ability of these strains to secrete proteolytic enzymes against CD4+ T-lymphocyte surface receptors could provide an additional immunomodulatory mechanism in Candida albicans invasion.
About the Authors
I. D. ReshetnikovaRussian Federation
Yu. A. Tyurin
Russian Federation
N. I. Glushko
Russian Federation
S. A. Lisovskaya
Russian Federation
I. G. Mustafin
Russian Federation
R. S. Fassakhov
Russian Federation
References
1. Buhl R. Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma. Allergy. 2006; 61: 518–526.
2. Roland J.N., Bhalla R.K., Earis J. The local side effects of inhaled corticosteroids: current understanding and review of the literature. Chest. 2004; 126: 213–219.
3. Salzman G.A., Pyszczynski D.R. Oropharyngeal candidiasis in patients treated with beclomethasonedipropionate delivered by metered dose inhaler alone and with aerochamber. J. Allergy Clin. Immunol. 1988; 81: 424–428.
4. Adams N.P., Bestall J.C., Jones P.W.et al. Inhaled fluticasone at different doses for chronic asthma in adults and children. Cochrane Database Syst. Rev. 2005; 20; (3): CD003534.
5. Сергеев А.Ю., Сергеев Ю.В. Грибковые инфекции. Руководство для врачей. 2 изд. М.: Издательство "БИНОМ"; 2008. / Sergeev A.Yu., Sergeev Yu.V. Fungal Infections: Practical Guidelines. [Gribkovye infektsii. Rukovodstvo dlya vrachey]. 2nd ed. Moscow: BINOM; 2008 (in Russian).
6. Kurta E., Yildirima H., Kirazb N. et al. Erginela Oropharyngeal candidiasis with dry-powdered fluticasonepropionate: 500 mg / day versus 200 mg / day. Allergol. Immunol. Pathol. 2008; 36 (1): 17–20.
7. Лисовская С.А., Глушко Н.И., Халдеева Е.В. Адгезивные свойства штаммов Candida albicans при кандидозах различной локализации. Проблемы медицинской микологии. 2007; 9 (1): 26–29. / Lisovskaya S.A., Glushko N.I., Khaldeeva E.V. Adhesive properties of Candida albicans strains in candidosis of different sites. Problemy meditsinskoy mikologii. 2007; 9 (1): 26–29 (in Russian).
8. Куликов С.Н., Тюрин Ю.А., Фассахов Р.С. и др. Способ определения IgG-протеиназной активности. Патент РФ № 2373538, 2009. / Kulikov S.N., Tyurin Yu.A., Fassakhov R.S. et al. A method to measure proteinase activity. Patent RF № 2373538. 2009 (in Russian).
Review
For citations:
Reshetnikova I.D., Tyurin Yu.A., Glushko N.I., Lisovskaya S.A., Mustafin I.G., Fassakhov R.S. VIRULENT PROPERTIES OF GENUS CANDIDA IN PATIENTS WITH PERSISTENT BRONCHIAL ASTHMA AND LONG-TERM TREATMENT WITH INHALED STEROIDS. PULMONOLOGIYA. 2014;(3):73-77. (In Russ.) https://doi.org/10.18093/0869-0189-2014-0-3-73-77